What the Next Generation of Cancer Biomarkers May Involve
Video Categories: 2018 ASCO Insights, Biomarkers, and Video LibraryDr Sanjiv Agarwala predicts that the cancer biomarkers of the future may be “mobile biomarkers,” meaning measures of the tumor microenvironment or immune response that change with therapy and may be able to determine treatment efficacy.
Related Videos
Payer Coverage in Polycythemia Vera
Ken Schaecher, MD, Medical Director of SelectHealth, describes in his opinion how there is no payer coverage issues with patients with polycythemia vera at this time. Supported through funding from Incyte
New Data Coming Out of ASCO
Hear Dr. Michaelis describe the new data coming out of ASCO regarding polycythemia vera including new medicine.Supported through funding from Incyte